Treatments
930 articles
Understanding Who Is at High Risk for Pancreatic Cancer
Who is high-risk for pancreatic cancer? Oncologist Dr. Matthew Yurgelun explains high-risk populations and what steps to take if you meet the criteria.
Pancreatic Enzymes Explained
GI cancer specialist Dr. Shaalan Beg and dietician Shelli Hardy explain how pancreatic enzymes work in digestion and why pancreatic cancer patients may need them.
Unraveling the Web for Reliable Pancreatic Cancer Information
Dr. Mark Lewis and journalist Steve Doig explain how to judge whether the information about pancreatic cancer on the internet is from a reliable source.
What You Should Know About Tumor Boards
A tumor board brings together experts in different treatment fields to discuss your case and help direct your pancreatic cancer treatment.
Two-Drug Combo Targets KRAS and Fights Resistance
Researcher Hervé Tiriac leads a clinical trial for a new drug combination targeting KRAS and chemotherapy resistance.
Chemotherapy Regimen for Post-Surgery PNET Patients
Will a chemotherapy combination be effective against PNET after high-grade tumors are surgically removed? A clinical trial takes a closer look.
When Certain Chemotherapy Drugs Are in Short Supply
It’s been all over the news–some chemotherapy drugs are in short supply. Dr. Allyson Ocean explains a doctor’s options in these situations.
AI Platform Reveals Hidden Biology of Tumor Formation
Dr. Laura Wood and colleagues are developing an artificial intelligence (AI) platform to identify tumors as they are forming.
For Tommy Thompson, the Commitment to Pancreatic Cancer Research Is Personal
Former Wisconsin Governor Tommy Thompson is an advocate for pancreatic cancer research because he lost both his brothers to the disease.
Let’s Win Announces Let’s Learn Webinar Series
Are you a health care professional who wants to know more about the risks, symptoms, and treatments for pancreatic cancer? Join our webinars!